Newland Pharmaceutical Co., Ltd. (SHE:301277)
China
· Delayed Price · Currency is CNY 11.53
0.00 (0.00%)
Apr 29, 2026, 4:00 PM EDT
Newland Pharmaceutical Market Cap
Newland Pharmaceutical has a market cap or net worth of 4.52 billion as of April 29, 2026. Its market cap has decreased by -14.09% in one year.
Market Cap
4.52B
Enterprise Value
3.86B
Revenue
659.54M
Ranking
n/a
PE Ratio
44.75
Stock Price
11.53
Market Cap Chart
Since November 16, 2022, Newland Pharmaceutical's market cap has decreased from 5.31B to 4.52B, a decrease of -14.83%. That is a compound annual growth rate of -4.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 4.52B | -2.21% |
| Dec 31, 2025 | 4.62B | 19.35% |
| Dec 31, 2024 | 3.87B | -6.96% |
| Dec 29, 2023 | 4.16B | 8.12% |
| Dec 30, 2022 | 3.85B | -27.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jinhe Biotechnology CO., LTD. | 4.51B |
| Jinling Pharmaceutical Company | 4.55B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 4.55B |
| Tibet Weixinkang Medicine | 4.58B |
| Zhuhai Rundu Pharmaceutical | 4.45B |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 4.61B |
| Shandong Sinobioway Biomedicine | 4.69B |
| Shandong Wohua Pharmaceutical | 4.35B |